Frier Levitt co-founding partner Daniel Frier is featured in a RevCycle Intelligence article, “Breaking Down the FTC Noncompete Ban, Its Impact on Healthcare.” The article discusses the Federal Trade Commission’s recent final rule banning non-compete clauses between employers and employees and its implications on the healthcare industry. Dan shares his legal insights on the matter, delving into challenges that lie ahead and discussing important clarifications.
To read the article along with Dan’s intel, visit: https://revcycleintelligence.com/features/breaking-down-the-ftc-noncompete-ban-its-impact-on-healthcare
